secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K/A
Filed at:   2024-05-30T23:59:59+00:00
Accession:  0001493152-24-021990
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio Inc reports 2023 net loss of $60.5M; cash only $1.05M, going concern raised
--------------------------------------------------------------------------------

- Net loss of $60.5M in 2023 ($2.44/share) vs $22.0M in 2022; no revenue.
- Operating expenses $8.8M; $50.4M non-cash loss from change in fair value of convertible notes.
- Accumulated deficit $99.7M; cash $1.05M at Dec 31, 2023.
- Auditors express substantial doubt about ability to continue as going concern.
- Post-balance sheet: $2M Series A Preferred (Feb 2024) and $1.2M Series A-1 Preferred.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224021990/0001493152-24-021990-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224021990/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-021990

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer